Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

41.91
BATS BZX Real-Time Price
As of 3:11pm ET
 -0.33 / -0.78%
Today’s Change
37.20
Today|||52-Week Range
45.58
+8.83%
Year-to-Date

Today’s Trading

Previous close42.24
Today’s open42.07
Day’s range41.81 - 42.20
Volume268,583
Average volume (3 months)2,788,620
Market cap$103.9B
Dividend yield5.95%
Data as of 3:11pm ET, 07/25/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+12.44%
Earnings growth (next 5 years)+5.90%
Revenue growth (last year)+2.85%
P/E ratio61.3
Price/Sales2.52
Price/Book74.02

Competitors

 Today’s
change
Today’s
% change
CELGCelgene-1.01-0.73%
LLYEli Lilly and Co-3.13-3.69%
BMYBristol-Myers Squibb+0.39+0.70%
ABBVAbbVie-1.23-1.66%
Data as of 3:11pm ET, 07/25/2017

Financials

Next reporting dateJuly 26, 2017
EPS forecast (this quarter)$0.68
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts